5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

FDC Ltd.

•
fdcindia.comBSE: 531599NSE: FDC
Market Cap₹ 5,549 Cr.
Current Price
High / Low₹ 528 / 313
Stock P/E19.0
Book Value₹ 161
Price to Book2.10
Dividend Yield1.47 %
ROCE15.9 %
ROE11.8 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has consistently been profitable over the last 5 years
  • Company generates healthy free cash flow
  • Stock looks reasonably valued - P/E of 19.0 is below its historical median

CONS

  • Receivables are growing faster than sales - a possible quality concern
  • A large part of profit comes from other income (30.3% of PBT)
  • Company has delivered a poor profit growth of -1.3% over past five years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.FDC340.8518.975549.381.47132.499.18667.692.9715.9321.42
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
536486458462638514464492648473465585668
414410374406492444417438508439412478541
Operating Profit1227684561477047541403452106127
OPM %22.75%15.71%18.29%12.19%22.97%13.65%10.05%10.97%21.65%7.15%11.25%18.19%19.03%
2927252028351916362105048
Interest1111111111121
Depreciation10101010111413161515151415
Profit before Tax1419398651639051531603836140175
Tax %21.98%24.74%18.83%29.03%26.85%19.96%27.63%27.46%24.05%25.52%22.21%26.33%24.16%
Net Profit00001197237391212828103132
6.624.224.862.847.314.432.282.387.451.751.746.358.14

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
1,0141,0751,0911,3441,3331,5281,7841,9432,1082,1712,190
7708488601,0519991,2741,5341,6041,7831,8251,871
Operating Profit243227231293334254250339325346319
OPM %24.01%21.09%21.18%21.79%25.06%16.60%13.99%17.42%15.41%15.94%14.59%
445142699576511029193118
Interest11133344555
Depreciation3535333738373940545959
Profit before Tax252241237320388289258396357375390
Tax %25.13%27.89%28.25%25.03%22.32%25.30%24.82%23.01%25.31%24.87%24.89%
Net Profit189174170240301216194305267281293
EPS10.609.769.7413.9417.7212.8111.6618.7416.3917.29—
Dividend Payout %21.22%0.00%0.00%5.70%0.00%0.00%0.00%0.00%30.51%28.93%—

COMPOUNDED SALES GROWTH

10 Years:
8%
5 Years:
10%
3 Years:
7%

COMPOUNDED PROFIT GROWTH

10 Years:
5%
5 Years:
-1%
3 Years:
13%

STOCK PRICE CAGR

10 Years:
4%
5 Years:
0%
3 Years:
-3%
1 Year:
-27%

RETURN ON EQUITY

10 Years:
14%
5 Years:
12%
3 Years:
13%
Last Year:
12%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2023

Aug 25

₹ 500.00

The Board has decided August 25, 2023 as the record date for the purpose of Buyback offer

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital18171717171717161616
Minority Interest0000-0-0-1000
1,2521,2591,4281,5301,7171,9401,9652,0812,2652,469
4521082521131211
Trade Payables75977811877137178186205207
5285896477528379199991,0211,1451,236
Total Liabilities1,8761,9682,1722,4272,6553,0383,1803,3173,6433,939
678674682674689705699680852999
Capital Work in Progress31012241910519826113696
4914715856657908858068431,0281,048
137160174210215305329389375355
0000000117109152
Cash & Bank28292132323925265350
5386236978229109991,1241,0001,0911,238
Total Assets1,8761,9682,1722,4272,6553,0383,1803,3173,6433,939

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
228218186335302241232221318200
Cash from Investing-14420-120-98-77-14511-17-200-110
Cash from Financing0-169-0-142-129-10-180-202-92-93
111-81017-14226-3

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
69.6669.6669.6669.6669.6669.6669.6669.6669.66
2.512.622.672.562.412.442.322.401.40
6.726.036.086.377.176.816.276.296.31
Government0.000.000.000.000.000.000.000.000.00
21.1021.7021.5921.4220.7621.1021.7521.6522.63

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Copy of Newspaper Publication

2026-09-04 - FDC Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-01
Record Date

2026-09-01 - FDC Limited has informed the Exchange that Record date for the purpose of Meeting is 16-Sep-2026.

2026-09-01
Shareholders meeting

2026-09-01 - FDC Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026

2026-09-01
Copy of Newspaper Publication

2026-09-01 - FDC Limited has informed the Exchange about the newspaper publication in respect of the 86th AGM.

2026-08-27
General Updates

2026-08-27 - FDC Limited has informed the Exchange about Interim Stay received from The Honourable High Court of Delhi, New Delhi

2026-08-13
General Updates

2026-08-13 - FDC Limited has informed the Exchange about Marketing Authorisation received by its subsidiary, FDC International Ltd, from MHRA, UK, for Atropine 1.0% w/v Eye Drops, Solution.

2026-08-05
Press Release

2026-08-05 - FDC Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Press Release Q1 FY 2026-2027 Results".

2026-08-05
Outcome of Board Meeting

2026-08-05 - FDC Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-07-27
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-27 - FDC Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for FDC

Loading news…

🤖

AI Stock Analyst

FDC Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login